Literature DB >> 8197779

Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials.

U Veronesi1, A Luini, V Galimberti, S Zurrida.   

Abstract

The most recent analysis of the results of three major trials on breast conservation carried out at the Milan Cancer Institute between 1973 and 1988 showed that breast conservation consisting of a wide breast resection (quadrantectomy) plus radiotherapy is a safe procedure, and that there are no differences in long-term survival (up to 19 years) compared with women who have undergone Halsted's mastectomy. The studies also showed that reducing the extent of surgery from quadrantectomy to lumpectomy increases the risk of local recurrence by nearly three times, as does withdrawing radiotherapy. However, in women older than 55 years, quadrantectomy alone (without radiotherapy) may yield good results. Among the risk factors for local recurrence, a young age and the presence of an extensive intraductal component are the most significant.

Entities:  

Mesh:

Year:  1994        PMID: 8197779     DOI: 10.1007/bf00348194

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award.

Authors:  J Hayward; M Caleffi
Journal:  Arch Surg       Date:  1987-11

2.  Contralateral breast cancer after limited surgery plus radiotherapy of early mammary tumors.

Authors:  R Zucali; A Luini; M Del Vecchio; V Sacchini; E Sverzellati; C Stucchi; A Banfi; U Veronesi
Journal:  Eur J Surg Oncol       Date:  1987-10       Impact factor: 4.424

3.  Quadrantectomy versus lumpectomy for small size breast cancer.

Authors:  U Veronesi; F Volterrani; A Luini; R Saccozzi; M Del Vecchio; R Zucali; V Galimberti; A Rasponi; E Di Re; P Squicciarini
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

4.  Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

Authors:  U Veronesi; A Banfi; B Salvadori; A Luini; R Saccozzi; R Zucali; E Marubini; M Del Vecchio; P Boracchi; S Marchini
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

5.  Radiotherapy after breast-preserving surgery in women with localized cancer of the breast.

Authors:  U Veronesi; A Luini; M Del Vecchio; M Greco; V Galimberti; M Merson; F Rilke; V Sacchini; R Saccozzi; T Savio
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

6.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

  6 in total
  17 in total

1.  Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.

Authors:  Eline E Deurloo; William F A Klein Zeggelink; H Jelle Teertstra; Johannes L Peterse; Emiel J Th Rutgers; Sara H Muller; Harry Bartelink; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2005-11-19       Impact factor: 5.315

2.  Impact of intraoperative specimen mammography on margins in breast-conserving surgery.

Authors:  Tomoka Hisada; Masataka Sawaki; Junko Ishiguro; Yayoi Adachi; Haruru Kotani; Akiyo Yoshimura; Masaya Hattori; Yasushi Yatabe; Hiroji Iwata
Journal:  Mol Clin Oncol       Date:  2016-07-04

3.  Reconstruction of the breast conservation deformity.

Authors:  Sumner A Slavin; Terri Halperin
Journal:  Semin Plast Surg       Date:  2004-05       Impact factor: 2.314

4.  Nerve-sparing axillary dissection using the da Vinci Surgical System.

Authors:  Susan M L Lim; Cheng K Kum; Foong L Lam
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

5.  Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients.

Authors:  Ali Arab Kheradmand; Neda Ranjbarnovin; Zahra Khazaeipour
Journal:  World J Surg Oncol       Date:  2010-04-17       Impact factor: 2.754

6.  Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update).

Authors:  Hugh Scarth; Jacques Cantin; Mark Levine
Journal:  CMAJ       Date:  2002-07-23       Impact factor: 8.262

Review 7.  Radiation therapy for early breast cancer.

Authors:  Georgios Koukourakis
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

8.  The effect of simulation on recurrence after breast-conserving surgery and radiotherapy: preliminary results.

Authors:  Ji-Yoon Kim; Yeon-Sil Kim; Mi-Ryung Ryu; Sung-Whan Kim; Chul-Seung Kay; Sei-Chul Yoon; Woo-Chan Park; Byung-Joo Song; Se-Jeong Oh; Sang-Seol Jung; Jong-Man Won; Seung-Nam Kim; Su-Mi Chung
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

9.  Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.

Authors:  Giovanni Paganelli; Concetta De Cicco; Mahila E Ferrari; Giuseppe Carbone; Gianmatteo Pagani; Maria Cristina Leonardi; Marta Cremonesi; Annamaria Ferrari; Monica Pacifici; Amalia Di Dia; Rita De Santis; Viviana Galimberti; Alberto Luini; Roberto Orecchia; Stefano Zurrida; Umberto Veronesi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-04       Impact factor: 9.236

10.  Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.

Authors:  Sepideh Gholami; Chun-Hao Chen; Laurence J Belin; Emil Lou; Sho Fujisawa; Caroline Antonacci; Amanda Carew; Nanhai G Chen; Marina De Brot; Pat B Zanzonico; Aladar A Szalay; Yuman Fong
Journal:  Breast Cancer Res       Date:  2013-03-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.